Rubella vaccine

Rubella Vaccine

The Rubella Vaccine (/ruːˈbɛlə vaksin/), also known as the MMR vaccine when combined with vaccines for Measles and Mumps, is a vaccine used to prevent Rubella or German measles.

Etymology

The term "Rubella" is derived from Latin, meaning "little red". It was first standardized as a term in 1866 by German physicians, referring to the characteristic red rash observed in patients. The term "vaccine" comes from the Latin vaccinus, meaning "from cows", due to the early use of cowpox virus to immunize against smallpox.

Usage

The Rubella Vaccine is typically administered in two doses: the first between 12 and 15 months of age, and the second between 4 and 6 years of age. These doses can be given earlier if needed. The vaccine is given by injection.

Effectiveness

The Rubella Vaccine is highly effective at preventing Rubella. After two doses, 97% of people are protected. The vaccine also helps protect against Congenital Rubella Syndrome, a condition that can occur when a pregnant woman contracts Rubella.

Side Effects

Common side effects of the Rubella Vaccine include fever and a mild rash. More serious side effects are rare but can include Arthritis and Encephalitis.

History

The Rubella Vaccine was first licensed in 1969 in the United States. It was developed by Maurice Hilleman at Merck Institute of Therapeutic Research.

Related Terms

• Vaccination
• Immunization
• Virus
• Infection
• Pregnancy

External links

• Medical encyclopedia article on Rubella vaccine
• Wikipedia's article - Rubella vaccine

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski